Dr. Kolibaba on Mechanism of Action With Entospletinib in MCL
December 23rd 2016Kathryn Kolibaba, MD, co-chair, Hematology Research Committee, US Oncology Research, discusses the mechanism of action with entospletinib (GS-9973) and its potential as a treatment for patients with mantle cell lymphoma (MCL).
Read More